Literature DB >> 12471262

A role for the protease falcipain 1 in host cell invasion by the human malaria parasite.

Doron C Greenbaum1, Amos Baruch, Munira Grainger, Zbynek Bozdech, Katlin F Medzihradszky, Juan Engel, Joseph DeRisi, Anthony A Holder, Matthew Bogyo.   

Abstract

Cysteine proteases of Plasmodium falciparum are required for survival of the malaria parasite, yet their specific cellular functions remain unclear. We used a chemical proteomic screen with a small-molecule probe to characterize the predominant cysteine proteases throughout the parasite life cycle. Only one protease, falcipain 1, was active during the invasive merozoite stage. Falcipain 1-specific inhibitors, identified by screening of chemical libraries, blocked parasite invasion of host erythrocytes, yet had no effect on normal parasite processes such as hemoglobin degradation. These results demonstrate a specific role for falcipain 1 in host cell invasion and establish a potential new target for antimalarial therapeutics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471262     DOI: 10.1126/science.1077426

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  76 in total

1.  An activity-based imaging probe for the integral membrane hydrolase KIAA1363.

Authors:  Jae Won Chang; Raymond E Moellering; Benjamin F Cravatt
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-07       Impact factor: 15.336

2.  Phosphatidylinositol 3,4,5-trisphosphate activity probes for the labeling and proteomic characterization of protein binding partners.

Authors:  Meng M Rowland; Heidi E Bostic; Denghuang Gong; Anna E Speers; Nathan Lucas; Wonhwa Cho; Benjamin F Cravatt; Michael D Best
Journal:  Biochemistry       Date:  2011-11-30       Impact factor: 3.162

3.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

4.  Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis.

Authors:  Xuchu Que; Annette Wunderlich; Keith A Joiner; Sharon L Reed
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 5.  Toxoplasma gondii: the model apicomplexan.

Authors:  Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

6.  How chemoproteomics can enable drug discovery and development.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2012-01-27

7.  High-resolution functional proteomics by active-site peptide profiling.

Authors:  Eric S Okerberg; Jiangyue Wu; Baohong Zhang; Babak Samii; Kelly Blackford; David T Winn; Kevin R Shreder; Jonathan J Burbaum; Matthew P Patricelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

8.  Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.

Authors:  Manoj K Ramjee; Nicholas S Flinn; Tracy P Pemberton; Martin Quibell; Yikang Wang; John P Watts
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

9.  Proteomic profiling of metalloprotease activities with cocktails of active-site probes.

Authors:  Stephan A Sieber; Sherry Niessen; Heather S Hoover; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2006-03-26       Impact factor: 15.040

10.  Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.

Authors:  S Eksi; B Czesny; G-J van Gemert; R W Sauerwein; W Eling; K C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.